Gilead Buys Triangle; Viread/Coviracil Fixed-Dose Combo Launch Set For 2005

09 Dec 2002

• By The Pink Sheet

Gilead Sciences expects to launch a Viread/Coviracil fixed-dose combination treatment for HIV by 2005 following its acquisition of Coviracil developer Triangle Pharmaceuticals

Gilead Buys Triangle; Viread/Coviracil Fixed-Dose Combo Launch Set For 2005

More from Archive

More from Pink Sheet